Philip Morris

US FDA Grants First Market Authorisation Of Nicotine Pouches To Zyn

The US Food and Drug Administration authorised the marketing of 20 Zyn products, marking the first such move by the regulator for the fast-growing nicotine...

Altria Posts Better-Than-Expected Q3 Results On Robust Demand For Vapes, Nicotine Pouches

Altria Group beats market expectations for third-quarter revenue and profit, as robust demand for its nicotine pouches and e-cigarettes helped soften...

Philip Morris Raises Annual Profit Forecast On Strong Demand For Nicotine Pouches

Philip Morris International raised its annual profit forecast after beating third-quarter estimates, betting on higher prices and resilient demand for its...

Philip Morris Faces Key Test With US Heated Tobacco Push

Philip Morris International's goals for heated tobacco in the United States are reachable, analysts and investors say, even though rivals see limited poten...

Altria Edges Past Quarterly Profit Expectations On Higher Pricing

Marlboro maker Altria edged past fourth-quarter adjusted profit expectations, as higher prices and a shift to alternative nicotine products helpe...

Tobacco Firms' Transition Under Fire As WHO Targets Vaping

Tobacco firms that are shifting to new nicotine products have the most to lose if tobacco alternatives face the same rules as cigarettes.

Top 10 European Markets By Consumption Of Contraband And Counterfeit Cigarettes

A new study by KPMG, commissioned by Philip Morris, has found that consumption of contraband and counterfeit cigarettes in the EU27 grew by 0.7% last year,...